Cargando…
Improved HIV and Substance Abuse Treatment Outcomes for Released HIV-Infected Prisoners: The Impact of Buprenorphine Treatment
HIV-infected prisoners fare poorly after release. Though rarely available, opioid agonist therapy (OAT) may be one way to improve HIV and substance abuse treatment outcomes after release. Of the 69 HIV-infected prisoners enrolled in a randomized controlled trial of directly administered antiretrovir...
Autores principales: | Springer, Sandra Ann, Chen, Shu, Altice, Frederick L. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer US
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2900572/ https://www.ncbi.nlm.nih.gov/pubmed/20177974 http://dx.doi.org/10.1007/s11524-010-9438-4 |
Ejemplares similares
-
Retention on Buprenorphine Is Associated with High Levels of Maximal Viral Suppression among HIV-Infected Opioid Dependent Released Prisoners
por: Springer, Sandra A., et al.
Publicado: (2012) -
Correlates of HIV infection and being unaware of HIV status among soon-to-be-released Ukrainian prisoners
por: Azbel, Lyuba, et al.
Publicado: (2014) -
Emergency Department Use by Released Prisoners with HIV: An Observational Longitudinal Study
por: Meyer, Jaimie P., et al.
Publicado: (2012) -
A comparison of psychiatric diagnoses among HIV-infected prisoners receiving combination antiretroviral therapy and transitioning to the community
por: Di Paola, Angela, et al.
Publicado: (2014) -
Predictors of Linkage to and Retention in HIV Care Following Release from Connecticut Jails and Prisons
por: Loeliger, Kelsey B, et al.
Publicado: (2017)